NEWS: XT-Thrive^®, the Standard for Non-Toxic Cryopreservation, Now Available in cGMP Grade. Discover >

News

Organ Preservation, XT-ViVo & TimeSeal

X-Therma is granted by U.S. Department of Defense for Phase I research

May 28, 2015
Arthi Shridhar

X-Therma is granted by U.S. Department of Defense for Phase I research on developing breakthrough cryoprotective agents (CPAs) for large organ/tissue cryopreservation!

Find the whole article here:

This article is posted on Scientific American

More News

X-Therma Achieves World’s First Subzero Organ Transports: Multiple 48-Hour Transatlantic Journeys Support First Steps Toward Tackling Organ Waitlist

X-Therma Achieves GMP Commercial Readiness with XT-Thrive^®

X-Therma Announces XT-Thrive^® Drug Master File (DMF) Accepted by U.S. Food and Drug Administration (FDA)

X-Therma, Inc.

North America

625 Alfred Nobel Drive
Suite B
Hercules, CA 94547
USA

Europe

X-Therma GmbH
Langer Weg 11
6020 Innsbruck
Austria

info@x-therma.com

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.

Necessary

Always Enabled

Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.

Cookie	Duration	Description
cookielawinfo-checkbox-advertisement	1 year	Set by the GDPR Cookie Consent plugin, this cookie is used to record the user consent for the cookies in the "Advertisement" category .
cookielawinfo-checkbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
CookieLawInfoConsent	1 year	Records the default button state of the corresponding category & the status of CCPA. It works only in coordination with the primary cookie.
elementor	never	This cookie is used by the website's WordPress theme. It allows the website owner to implement or change the website's content in real-time.
JSESSIONID	session	The JSESSIONID cookie is used by New Relic to store a session identifier so that New Relic can monitor session counts for an application.
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.

Statistics

Cookie	Duration	Description
_ga	2 years	The _ga cookie, installed by Google Analytics, calculates visitor, session and campaign data and also keeps track of site usage for the site's analytics report. The cookie stores information anonymously and assigns a randomly generated number to recognize unique visitors.
_ga_VYWSHLVBR2	2 years	This cookie is installed by Google Analytics.
bscookie	1 year	LinkedIn sets this cookie to store performed actions on the website.
lang	session	LinkedIn sets this cookie to remember a user's language setting.
lidc	1 day	LinkedIn sets the lidc cookie to facilitate data center selection.

Marketing

Cookie	Duration	Description
bcookie	1 year	LinkedIn sets this cookie from LinkedIn share buttons and ad tags to recognize browser ID.
CONSENT	2 years	YouTube sets this cookie via embedded youtube-videos and registers anonymous statistical data.
li_alerts	1 year	No description
li_gc	5 months 27 days	Linkedin set this cookie for storing visitor's consent regarding using cookies for non-essential purposes.
VISITOR_INFO1_LIVE	5 months 27 days	A cookie set by YouTube to measure bandwidth that determines whether the user gets the new or old player interface.
YSC	session	YSC cookie is set by Youtube and is used to track the views of embedded videos on Youtube pages.
yt-remote-connected-devices	never	YouTube sets this cookie to store the video preferences of the user using embedded YouTube video.
yt-remote-device-id	never	YouTube sets this cookie to store the video preferences of the user using embedded YouTube video.
yt.innertube::nextId	never	This cookie, set by YouTube, registers a unique ID to store data on what videos from YouTube the user has seen.
yt.innertube::requests	never	This cookie, set by YouTube, registers a unique ID to store data on what videos from YouTube the user has seen.

News

X-Therma is granted by U.S. Department of Defense for Phase I research

Find the whole article here:

More News

X-Therma Achieves World’s First Subzero Organ Transports: Multiple 48-Hour Transatlantic Journeys Support First Steps Toward Tackling Organ Waitlist

X-Therma Achieves GMP Commercial Readiness with XT-Thrive^®

X-Therma Announces XT-Thrive^® Drug Master File (DMF) Accepted by U.S. Food and Drug Administration (FDA)

North America

Europe

NORTH AMERICA

EUROPE

News

X-Therma is granted by U.S. Department of Defense for Phase I research

Find the whole article here:

More News

X-Therma Achieves World’s First Subzero Organ Transports: Multiple 48-Hour Transatlantic Journeys Support First Steps Toward Tackling Organ Waitlist

X-Therma Achieves GMP Commercial Readiness with XT-Thrive®

X-Therma Announces XT-Thrive® Drug Master File (DMF) Accepted by U.S. Food and Drug Administration (FDA)

North America

Europe

NORTH AMERICA

EUROPE

X-Therma Achieves GMP Commercial Readiness with XT-Thrive^®

X-Therma Announces XT-Thrive^® Drug Master File (DMF) Accepted by U.S. Food and Drug Administration (FDA)